GWave

Noninvasive Glucose Monitoring

Health Tech & Life Sciences
Active
Series C Haifa Founded 2017
Website ↗
Total raised
$21.1M
Last: Series C 2023-08
Stage
Series C
Founded
2017
Headcount
6
HQ
Haifa
Sector
Health Tech & Life Sciences

About

GWave is a noninvasive glucometer that utilizes radio frequency waves to continuously measure blood glucose levels in real time. Its sensors are developed with proprietary AI algorithms, making GWave cost efficient, compact, and capable of delivering exceptionally accurate measurements.

GWave seamlessly connects to Bluetooth and smartphones, creating a painless, straightforward, and pleasant user experience. Users can track their glucose readings as frequently as needed, and the built-in automated alarm feature ensures proper notification of fluctuations in glucose levels.

The company's cloud securely stores all of the users' measurement data and can deliver important information to caretakers and medical professionals. GWave's software is safe, secure, and reliable.

GWave was developed by Hagar Technology.

Funding history · 3 rounds · $21.1M total

2023-08
Series C $5.0M
2021-08
Series B $11.7M
2021-07
Series A $4.4M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcareDigital Therapeutics
Technologies
SensingCommunicationsRadio FrequencyBluetoothArtificial IntelligencePlatforms & InterfacesSoftwareMobileData StorageCloud
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2C

Tags

digital-healthcaremedical-devicesnon-invasivedigital-therapeuticsalgorithmsrf-technologyartificial-intelligencealert-systemreal-timemonitoringcloud-basedmobile-applicationsdiabetessensors